Benjamin F. Edwards & Company’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $4K | Hold |
1,775
| – | – | ﹤0.01% | 1931 |
|
|
2024
Q1 | $4K | Hold |
1,775
| – | – | ﹤0.01% | 1908 |
|
|
2023
Q4 | $3K | Sell |
1,775
-3,766
| -68% | -$6.37K | ﹤0.01% | 1944 |
|
|
2023
Q3 | $11K | Hold |
5,541
| – | – | ﹤0.01% | 1367 |
|
|
2023
Q2 | $8K | Sell |
5,541
-3,595
| -39% | -$5.19K | ﹤0.01% | 1445 |
|
|
2023
Q1 | $19K | Sell |
9,136
-25,276
| -73% | -$52.6K | ﹤0.01% | 1275 |
|
|
2022
Q4 | $39K | Buy |
34,412
+15,157
| +79% | +$17.2K | ﹤0.01% | 1142 |
|
|
2022
Q3 | $31K | Hold |
19,255
| – | – | ﹤0.01% | 1164 |
|
|
2022
Q2 | $25K | Sell |
19,255
-8,581
| -31% | -$11.1K | ﹤0.01% | 1194 |
|
|
2022
Q1 | $45K | Sell |
27,836
-1,779
| -6% | -$2.88K | ﹤0.01% | 1055 |
|
|
2021
Q4 | $61K | Buy |
29,615
+6,015
| +25% | +$12.4K | ﹤0.01% | 997 |
|
|
2021
Q3 | $92K | Sell |
23,600
-11,093
| -32% | -$43.2K | ﹤0.01% | 872 |
|
|
2021
Q2 | $111K | Buy |
34,693
+23,993
| +224% | +$76.8K | 0.01% | 817 |
|
|
2021
Q1 | $23K | Buy |
10,700
+1,000
| +10% | +$2.15K | ﹤0.01% | 1167 |
|
|
2020
Q4 | $22K | Hold |
9,700
| – | – | ﹤0.01% | 1133 |
|
|
2020
Q3 | $26K | Buy |
9,700
+8,200
| +547% | +$22K | ﹤0.01% | 1054 |
|
|
2020
Q2 | $5K | Hold |
1,500
| – | – | ﹤0.01% | 1422 |
|
|
2020
Q1 | $3K | Hold |
1,500
| – | – | ﹤0.01% | 1532 |
|
|
2019
Q4 | $4K | Hold |
1,500
| – | – | ﹤0.01% | 1662 |
|
|
2019
Q3 | $6K | Hold |
1,500
| – | – | ﹤0.01% | 1527 |
|
|
2019
Q2 | $6K | Hold |
1,500
| – | – | ﹤0.01% | 1558 |
|
|
2019
Q1 | $8K | Hold |
1,500
| – | – | ﹤0.01% | 1373 |
|
|
2018
Q4 | $5K | Buy |
+1,500
| New | +$5K | ﹤0.01% | 1437 |
|